| 000 | 01035 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513061617.0 | ||
| 264 | 0 | _c19940324 | |
| 008 | 199403s 0 0 eng d | ||
| 022 | _a0002-953X | ||
| 024 | 7 |
_a10.1176/ajp.151.3.451 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBower, D J | |
| 245 | 0 | 0 |
_aWithdrawal-induced neuroleptic malignant syndrome. _h[electronic resource] |
| 260 |
_bThe American journal of psychiatry _cMar 1994 |
||
| 300 |
_a451-2 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAmantadine _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeuroleptic Malignant Syndrome _xdrug therapy |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 |
_aSubstance Withdrawal Syndrome _xdrug therapy |
| 700 | 1 | _aChalasani, P | |
| 700 | 1 | _aAmmons, J C | |
| 773 | 0 |
_tThe American journal of psychiatry _gvol. 151 _gno. 3 _gp. 451-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1176/ajp.151.3.451 _zAvailable from publisher's website |
| 999 |
_c8108986 _d8108986 |
||